Hepatitis C Combination Therapy - Vertex Pharma's Hep C Drug Could See $1.7B Sales

Vertex Pharma's Hep C Drug Could See $1.7B Sales
Forbes - Mar 14, 2006ThinkEquity Partners lowered the price target on Vertex Pharmaceuticals to $40 from $48 and said more data will be needed in order to determine the potential ...

Human Genome Sciences Seen Partnering Hep C Drug In 2006
Forbes - Mar 16, 2006Piper Jaffray maintained an "outperform" rating on Human Genome Sciences and advised investors to buy on recent weakness in the stock. ...

GoGirlsMusic.com Names HepCAware.org the Official Charity of the ...
PR Web (press release), WA - Mar 4, 2006... a GoGirls member, has received a lot of support from Madalyn Sklar, founder of GoGirls, including a GoGirlsMusic Sponsorship for her annual "Hep C Aware -- The ...

Human Genome hep. C data seen good but no home run
Reuters - Mar 14, 2006CHICAGO (Reuters) - Human Genome Sciences Inc. (HGSI.O: Quote, Profile, Research) on Tuesday released 12-week data on its experimental ...

Human Genome hep. C data seen good but no home run
Reuters - Mar 14, 2006CHICAGO (Reuters) - Human Genome Sciences Inc. (HGSI.O: Quote, Profile, Research) on Tuesday said interim results of a mid-stage ...